Related references
Note: Only part of the references are listed.Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop
Max E. Adrichem et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2016)
Pathogenesis of immune-mediated neuropathies
Marinos C. Dalakas
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy
Antonios Kerasnoudis et al.
JOURNAL OF NEUROIMAGING (2015)
INCAT DISABILITY SCORE: A CRITICAL ANALYSIS OF ITS MEASUREMENT PROPERTIES
Ari Breiner et al.
MUSCLE & NERVE (2014)
Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy
L. H. Markvardsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
LONG-TERM OUTCOME IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY PATIENTS TREATED WITH INTRAVENOUS IMMUNOGLOBULIN: A RETROSPECTIVE STUDY
Luis Querol et al.
MUSCLE & NERVE (2013)
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
Mohamed Mahdi-Rogers et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals
Elisabeth Frauger et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2011)
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature
L. Benedetti et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology
John D. Pollard et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2011)
Advances in the diagnosis, pathogenesis and treatment of CIDP
Marinos C. Dalakas
NATURE REVIEWS NEUROLOGY (2011)
Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy
Min-Suk Yoon et al.
Therapeutic Advances in Neurological Disorders (2011)
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy
D. Cocito et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision
P. Y. K. Van den Bergh et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
Bjoern Tackenberg et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2010)
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns et al.
BLOOD (2009)
Incidence and prevalence of CIDP and the association of diabetes mellitus
R. S. Laughlin et al.
NEUROLOGY (2009)
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
Richard A. C. Hughes et al.
LANCET NEUROLOGY (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Long-term effects of intravenous immunoglobulin in CIDP
S. Vucic et al.
CLINICAL NEUROPHYSIOLOGY (2007)
Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases
S Kuwabara et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy - Research report
DE Gladstone et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2005)
Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy
M Matsuda et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy
KC Gorson et al.
NEUROLOGY (2004)
Research criteria for defining patients with CIDP
HW Sander et al.
NEUROLOGY (2003)
Connecting impairment, disability, and handicap in immune mediated polyneuropathies
ISJ Merkies et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy
JR Mendell et al.
NEUROLOGY (2001)
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
A Samuelsson et al.
SCIENCE (2001)
Share Paper
